A case of interleukin-12 receptor β-1 deficiency with recurrent leishmaniasis

Pediatric Infectious Disease Journal

Volumn 26, Issue 4, 2007, Pages 366-368

  Sanal, Ozden ^a   Turkkani, Gulten ^a   Gumruk, Fatma ^a   Yel, Leman ^a   Secmeer, Gulten ^a   Tezcan, Ilhan ^a   Kara, Ates ^a   Ersoy, Fugen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Interleukin 12 receptor beta 1 deficiency; Leishmaniasis; Mendelian susceptibility to mycobacterial disease; Salmonella infection

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; CIPROFLOXACIN; GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR BETA1;

AMASTIGOTE; ANEMIA; ARTICLE; BLOOD; BONE MARROW; CASE REPORT; CONVALESCENCE; CYTOPENIA; ERYTHROPHAGOCYTOSIS; HUMAN; IMMUNE DEFICIENCY; LEISHMANIA; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; SALMONELLA; SCHOOL CHILD; SPLENOMEGALY; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANTI-INFECTIVE AGENTS; ANTIPROTOZOAL AGENTS; CHILD, PRESCHOOL; CIPROFLOXACIN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; RECEPTORS, INTERLEUKIN-12; RECURRENCE; SALMONELLA INFECTIONS;

EID: 34247172461     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000258696.64507.0f     Document Type: Article

References (20)

1. Altare F, Lammas D, Revy P, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest. 1998;102:2035-2040.
2. de Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998;280:1435-1438.
3. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581-620.
4. Fieschi C, Bosticardo M, de Beaucoudrey L, et al. A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surface-expressed nonfunctional receptors. Blood. 2004;104:2095-2101.
5. van de Vosse E, Hoeve MA, Ottenhoff T. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonella. Lancet Infect Dis. 2004;4:739-749.
6. Ozbek N, Fieschi C, Y?lmaz BT, et al. Interleukin-12 receptor beta1 chain deficiency in a child with disseminated tuberculosis. Clin Infect Dis. 2005;40:e55-e58.
7. Sanal O, Turul T, De Boer T, et al. Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections. J Clin Immunol. 2006;26:1-6.
8. Moraes-Vasconcelos D, Grumach AS, Yamaguti A, et al. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis. 2005;41:31-37.
9. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561-1577.
10. Pasquau F, Ena J, Sanchez R, et al. Leishmania HIV Mediterreanean Co-Operative Group. Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. Eur J Clin Microbiol Infect Dis. 2005;24:411-418.
11. Roberts MT. Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment. Br Med Bull. 2006;17:75-76.
12. Wilson ME, Jeronimo SMB, Pearson RD. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog. 2005;38:147-160.
13. Mattner F, Di Padova K, Alber G. Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect Immun. 1997;65:4378-4383.
14. Park AY, Hondowicz B, Kopf M, Scott P. The role of IL-12 in maintaining resistance to Leishmania major. J Immunol. 2002;168:5771-5777.
15. Torrentera FA, Laman JD, van Meurs M, et al. Endogenous Interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice. Infect Immun. 2002;70:5075-5080.
16. de Souza-Neto SM, Carnerio CM, Vieira LQ, Afonso LCC. Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice. Mem Inst Oswaldo Cruz. 2004;99:289-294.
17. Murray HW, Tsai CW, Liu J, Ma X. Responses to Leishmania donovani in mice deficient in Interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infect Immun. 2006;74:4370-4374.
18. Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol. 2002;32:3206-3215.
19. Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004;364:2113-2121.
20. Singh ZN, Rakheja D, Yadav TP, Shome DK. Infection-associated haemophagocytosis: the tropical spectrum. Clin Lab Haematol. 2005;27:312-315.